City

Basel (1)

Cincinnati (1)

Condition

Bronchiolitis Obliterans (BO) (2)

Bronchiolitis Obliterans Syndrome (BOS) (1)

Hematopoietic Stem Cell Transplant (HSCT) (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Children's Hospital Medical Center, Cincinnati (1)

University Hospital, Basel, Switzerland (1)

Collaborator

Intervention

nintedanib (1)

ruxolitinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

bronchiolitis obliterans (bo)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)

Recruiting

Hematopoietic Stem Cell Transplant (HSCT)
Bronchiolitis Obliterans (BO)

Ruxolitinib

Cincinnati, Ohio

Cincinnati Children's Hospital Medical Center

Aug 6, 2022

Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans (BO) Trial in Basel (Nintedanib)

Recruiting

Bronchiolitis Obliterans Syndrome (BOS)
Bronchiolitis Obliterans (BO)

Nintedanib

Basel, Switzerland
+1 more

May 4, 2022